Debora A. Jorn
2013
In 2013, Debora A. Jorn earned a total compensation of $1.7M as Executive Vice President, Company Group Chairman at Valeant Pharmaceuticals International.
Compensation breakdown
| Non-Equity Incentive Plan | $209,213 |
|---|---|
| Salary | $375,650 |
| Stock Awards | $1,076,255 |
| Other | $9,259 |
| Total | $1,670,377 |
Jorn received $1.1M in stock awards, accounting for 64% of the total pay in 2013.
Jorn also received $209.2K in non-equity incentive plan, $375.7K in salary and $9.3K in other compensation.
Rankings
In 2013, Debora A. Jorn's compensation ranked 4,534th out of 12,286 executives tracked by ExecPay. In other words, Jorn earned more than 63.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,534 out of 12,286 | 63rd |
Division Manufacturing | 1,549 out of 4,612 | 66th |
Major group Chemicals And Allied Products | 445 out of 1,466 | 70th |
Industry group Drugs | 308 out of 1,160 | 73rd |
Industry Pharmaceutical Preparations | 247 out of 890 | 72nd |
Source: SEC filing on April 29, 2016.
Jorn's colleagues
We found seven more compensation records of executives who worked with Debora A. Jorn at Valeant Pharmaceuticals International in 2013.
2013
Robert Chai-Onn
Valeant Pharmaceuticals International
Chief Legal Officer
2013
Laizer Kornwasser
Valeant Pharmaceuticals International
Group Chairman
2013
Daniel Wechsler
Valeant Pharmaceuticals International
Group Chairman
2013
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2013
Howard Schiller
Valeant Pharmaceuticals International
Chief Financial Officer
2013
Brian Stolz
Valeant Pharmaceuticals International
Senior Vice President and General Manager
2013
Pavel Mirovsky
Valeant Pharmaceuticals International